Apogee Therapeutics
APGE
APGE
85 hedge funds and large institutions have $1.17B invested in Apogee Therapeutics in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.64% more ownership
Funds ownership: 107.85% → 112.49% (+4.6%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
85
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$15.8M | |
| 2 | +$13.1M | |
| 3 | +$9.37M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$5.31M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.91M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$5.18M | |
| 3 | -$4.19M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$3.32M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.54M |